Rankings / Mitochondria & Cellular Energy

CoQ10 (ubiquinone/ubiquinol)

Mitochondria & Cellular Energy · Electron transport cofactor

Also known as: Coenzyme Q10 ·Ubiquinol ·Ubiquinone

Tier A+

Reviewed by Read Off Label · Last reviewed · How we grade

mitochondrialantioxidantubiquinolstatin-myopathyotc
8.2 / 10
Tier A+
Ev 8 Bn 6.5 Sf 9

Bottom line

Read Off Label grades CoQ10 (ubiquinone/ubiquinol) as A+ (8.2/10) based on strong evidence, med-high benefit magnitude, and a low-risk safety profile.

Q-SYMBIO trial (Mortensen 2014, JACC HF): 3x100 mg ubiquinone x 2 yr in NYHA III-IV HF; 18% cardiovascular mortality reduction; ~42% reduction in MACE.

Studied, labeled, or reported-use context: 100-300 mg/day with fat-containing meal; ubiquinol produces higher plasma CoQ10 in older adults;… — OTC; not individualized guidance.

What the evidence says

Q-SYMBIO trial (Mortensen 2014, JACC HF): 3x100 mg ubiquinone x 2 yr in NYHA III-IV HF; 18% cardiovascular mortality reduction; ~42% reduction in MACE. European subgroup analysis 2019 confirmed effect direction. 2024 systematic review of 16 studies replicated 40% HF-related mortality reduction signal. Statins can lower CoQ10 through the shared mevalonate pathway; a 2025 meta-analysis reported a modest reduction in statin-associated muscle pain. Endogenous levels decline with age, hence the elderly absorption argument for ubiquinol. **Ubiquinol vs ubiquinone caveat**: ubiquinol delivers ~3-4x higher plasma CoQ10 in adults >40 (more pronounced in elderly) per multiple bioavailability RCTs, but the strongest clinical outcome trials (Q-SYMBIO) used ubiquinone at 300 mg/day. Ubiquinol produces higher plasma levels in older adults, while pivotal clinical outcome trials used ubiquinone; direct evidence of superior clinical outcomes by form is absent.

Mechanism

Electron transport chain cofactor (complex III; mitochondrial ATP synthesis); lipid-soluble antioxidant in membranes and LDL; endogenous synthesis shares the mevalonate pathway with cholesterol — depleted by statins; ubiquinol = reduced/active form; ubiquinone = oxidized form (interconverted in vivo by NQO1 and other reductases)

Studied, labeled, or reported dose & route

100-300 mg/day with fat-containing meal; ubiquinol produces higher plasma CoQ10 in older adults; clinical outcome superiority over ubiquinone is not established; pivotal RCTs (Q-SYMBIO) used ubiquinone — bioavailability advantage of ubiquinol does NOT automatically translate to superior outcomes

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about CoQ10 (ubiquinone/ubiquinol)'s effects?
Read Off Label rates the evidence for CoQ10 (ubiquinone/ubiquinol) as Strong and the benefit magnitude as med-high, producing an overall grade of A+ (8.2/10). Q-SYMBIO trial (Mortensen 2014, JACC HF): 3x100 mg ubiquinone x 2 yr in NYHA III-IV HF; 18% cardiovascular mortality reduction; ~42% reduction in MACE.
What safety findings are reported for CoQ10 (ubiquinone/ubiquinol)?
CoQ10 (ubiquinone/ubiquinol) has a low risk profile in the database. Low Legal status: OTC.
What doses or routes are reported for CoQ10 (ubiquinone/ubiquinol)?
100-300 mg/day with fat-containing meal; ubiquinol produces higher plasma CoQ10 in older adults; clinical outcome superiority over ubiquinone is not established; pivotal RCTs (Q-SYMBIO) used ubiquinone — bioavailability advantage of ubiquinol does NOT automatically translate to superior outcomes This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does CoQ10 (ubiquinone/ubiquinol) work?
Electron transport chain cofactor (complex III; mitochondrial ATP synthesis); lipid-soluble antioxidant in membranes and LDL; endogenous synthesis shares the mevalonate pathway with cholesterol — depleted by statins; ubiquinol = reduced/active form; ubiquinone = oxidized form (interconverted in vivo by NQO1 and other reductases)

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.